News
Researchers at the University of Cincinnati are exploring ways to interrupt the lifecycle of the parasite behind Chagas ...
First children vaccinated in clinical study seeking to expand the target population for the chikungunya vaccine. COPENHAGEN, Denmark, June 12, 2025 - Bavarian Nordic A/S (OMX: BAVA) announced ...
COPENHAGEN, Denmark, June 12, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today the initiation of a Phase 3 clinical study of its single-dose, virus-like particle (VLP) chikungunya vaccine, CHIKV ...
Chagas disease is often called a silent killer because many people don't realize they have it until complications from the ...
We could be on the verge of a major cancer treatment breakthrough, with a new vaccine shown to completely obliterate pancreatic cancer cells in preclinical trials. This paves the way for it to move ...
University of Cincinnati biologists are studying the lifecycle of the Chagas disease parasite to develop a cure, aiming to ...
5d
AZoLifeSciences on MSNTargeting the Chagas Parasite by Interrupting Its LifecycleChagas disease is often called a silent killer because many people don't realize they have it until complications from the ...
3d
News-Medical.Net on MSNChikungunya vaccine could stop millions of infections worldwide, study findsA landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results